Fernández, A.; Cura-Cuevas, Y.; Rojo-Tolosa, S.; Gálvez-Navas, J.M.; González-Flores, E.; Pérez-RamÃrez, C.; Jiménez-Morales, A.
Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Genes and Their Contribution to Breast Cancer Therapy. Pharmaceutics 2026, 18, 633.
https://doi.org/10.3390/pharmaceutics18060633
AMA Style
Fernández A, Cura-Cuevas Y, Rojo-Tolosa S, Gálvez-Navas JM, González-Flores E, Pérez-RamÃrez C, Jiménez-Morales A.
Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Genes and Their Contribution to Breast Cancer Therapy. Pharmaceutics. 2026; 18(6):633.
https://doi.org/10.3390/pharmaceutics18060633
Chicago/Turabian Style
Fernández, Andrea, YasmÃn Cura-Cuevas, Susana Rojo-Tolosa, José MarÃa Gálvez-Navas, Encarnación González-Flores, Cristina Pérez-RamÃrez, and Alberto Jiménez-Morales.
2026. "Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Genes and Their Contribution to Breast Cancer Therapy" Pharmaceutics 18, no. 6: 633.
https://doi.org/10.3390/pharmaceutics18060633
APA Style
Fernández, A., Cura-Cuevas, Y., Rojo-Tolosa, S., Gálvez-Navas, J. M., González-Flores, E., Pérez-RamÃrez, C., & Jiménez-Morales, A.
(2026). Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Genes and Their Contribution to Breast Cancer Therapy. Pharmaceutics, 18(6), 633.
https://doi.org/10.3390/pharmaceutics18060633
